Human embryonic stem cell-derived keratinocytes exhibit an epidermal transcription program and undergo epithelial morphogenesis in engineered tissue constructs.
Human embryonic stem (hES) cells are an attractive source of cellular material for scientific, diagnostic, and potential therapeutic applications. Protocols are now available to direct hES cell differentiation to specific lineages at high purity under relatively defined conditions; however, researchers must establish the functional similarity of hES cell derivatives and associated primary cell types to validate their utility. Using retinoic acid to initiate differentiation, we generated high-purity populations of keratin 14+ (K14) hES cell-derived keratinocyte (hEK) progenitors and performed microarray analysis to compare the global transcriptional program of hEKs and primary foreskin keratinocytes. Transcriptional patterns were largely similar, though gene ontology analysis identified that genes associated with signal transduction and extracellular matrix were upregulated in hEKs. In addition, we evaluated the ability of hEKs to detect and respond to environmental stimuli such as Ca(2+), serum, and culture at the air-liquid interface. When cultivated on dermal constructs formed with collagen gels and human dermal fibroblasts, hEKs survived and proliferated for 3 weeks in engineered tissue constructs. Maintenance at the air-liquid interface induced stratification of surface epithelium, and immunohistochemistry results indicated that markers of differentiation (e.g., keratin 10, involucrin, and filaggrin) were localized to suprabasal layers. Although the overall tissue morphology was significantly different compared with human skin samples, organotypic cultures generated with hEKs and primary foreskin keratinocytes were quite similar, suggesting these cell types respond to this microenvironment in a similar manner. These results represent an important step in characterizing the functional similarity of hEKs to primary epithelia.
Metallo
Christian M
CM
Department of Chemical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Azarin
Samira M
SM
Moses
Laurel E
LE
Ji
Lin
L
de Pablo
Juan J
JJ
Palecek
Sean P
SP
D000970:Antineoplastic Agents / Q000494:pharmacology; D002460:Cell Line; D003094:Collagen; D053595:Embryonic Stem Cells / Q000166:cytology* / Q000378:metabolism*; D000078404:Epidermal Cells; D004817:Epidermis / Q000378:metabolism*; D005347:Fibroblasts / Q000166:cytology / Q000378:metabolism; D000091344:Filaggrin Proteins; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation / Q000187:drug effects / Q000502:physiology; D006801:Humans; D015603:Keratinocytes / Q000166:cytology* / Q000378:metabolism*; D008297:Male; D020411:Oligonucleotide Array Sequence Analysis; D023822:Tissue Engineering; D014158:Transcription, Genetic / Q000187:drug effects / Q000502:physiology*; D014212:Tretinoin / Q000494:pharmacology
D000970:Antineoplastic Agents; C000717249:FLG protein, human; D000091344:Filaggrin Proteins; D014212:Tretinoin; D003094:Collagen
Trends Cell Biol. 2006 Sep;16(9):467-76
16904320
J Dermatol Sci. 1998 Jul;17(3):167-81
9697045
Biotechnol Bioeng. 2008 Jul 1;100(4):830-7
18306423
Stem Cells. 2006 Aug;24(8):1956-67
16675594
Cell. 2007 Feb 9;128(3):445-58
17289566
J Invest Dermatol. 1983 Jul;81(1 Suppl):90s-5s
6345691
Stem Cells. 2005 Mar;23(3):315-23
15749926
Cytotechnology. 1992;9(1-3):163-71
1369170
Tissue Eng Part A. 2009 Nov;15(11):3417-26
19405784
Nature. 2007 Aug 30;448(7157):1015-21
17625568
Annu Rev Cell Dev Biol. 2007;23:93-113
17489688
Cancer Res. 2005 Mar 1;65(5):1783-91
15753375
J Invest Dermatol. 2001 May;116(5):633-40
11348449
Nat Biotechnol. 2006 Nov;24(11):1392-401
17053790
Stem Cells. 2008 Feb;26(2):440-4
18032703
Cell. 2004 Mar 19;116(6):769-78
15035980
Nat Protoc. 2009;4(1):44-57
19131956
Biotechnol Prog. 2007 Jan-Feb;23(1):18-23
17269664
Science. 1998 Nov 6;282(5391):1145-7
9804556
PLoS One. 2008 Jan 09;3(1):e1422
18183302
Eur J Cell Biol. 2005 Aug;84(8):709-18
16180309
J Cell Biol. 1985 Oct;101(4):1257-69
2413039
Cell. 1980 Jan;19(1):245-54
6153576
Glia. 2005 Feb;49(3):385-96
15538751
J Cell Mol Med. 2008 Jun;12(3):709-29
18194458
Nat Med. 2004 Jan;10(1):55-63
14702635
Methods Mol Biol. 2005;289:61-70
15502170
Genes Dev. 2005 Jul 1;19(13):1596-611
15961525
Proc Natl Sci Counc Repub China B. 2000 Oct;24(4):169-77
11087069
Hum Mol Genet. 2007 Oct 15;16 Spec No. 2:R243-51
17911167
Nat Methods. 2005 Mar;2(3):185-90
15782187
J Invest Dermatol. 1996 Sep;107(3):428-38
8751982
Cell. 1999 Oct 15;99(2):143-53
10535733
Clin Dermatol. 2005 Jul-Aug;23(4):403-12
16023936
Stem Cells. 2007 Jan;25(1):29-38
17204604
Biotechnol Bioeng. 2004 Nov 5;88(3):273-86
15493035
J Invest Dermatol. 2002 Jan;118(1):133-8
11851886
Nat Cell Biol. 2008 Sep;10(9):1027-38
19160483
Cell Tissue Res. 2008 Jan;331(1):103-7
17805576
J Cell Mol Med. 2005 Jul-Sep;9(3):592-608
16202208
Stem Cells. 2008 Feb;26(2):372-80
17962700
Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1792-7
16446420
Exp Cell Res. 1998 Feb 25;239(1):50-9
9511724
Cell. 1979 Nov;18(3):681-94
42494
Cell. 1981 Sep;25(3):617-25
6169442
Burns. 2006 Mar;32(2):135-8
16455203